Simulations Plus News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

19.11.24	Simulations Plus to Participate in the BTIG Digital Health Forum (Businesswire)
13.11.24	Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables (Businesswire)
06.11.24	Simulations Plus to Participate in the Stephens Annual Investment Conference (Businesswire)
30.10.24	Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations (Businesswire)
22.10.24	Ausblick: Simulations Plus öffnet die Bücher zum abgelaufenen Quartal (finanzen.net)
09.10.24	Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date (Businesswire)
08.10.24	Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings (Businesswire)
12.09.24	Breaking Down Simulations Plus: 2 Analysts Share Their Views (Benzinga)
28.08.24	Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (Businesswire)
23.08.24	Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions (Businesswire)
01.08.24	Simulations Plus Releases DILIsym® X (Businesswire)
30.07.24	Simulations Plus Releases ADMET Predictor® Version 12 (Businesswire)
29.07.24	Forecasting The Future: 4 Analyst Projections For Simulations Plus (Benzinga)
25.07.24	Simulations Plus to Participate in KeyBanc’s 25th Annual Technology Leadership Forum (Businesswire)
11.07.24	Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety (Businesswire)
03.07.24	Simulations Plus Posts Q3 Results, Joins First Foundation And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session (Benzinga)
01.07.24	Ausblick: Simulations Plus gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
20.06.24	Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit (Businesswire)
18.06.24	Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date (Businesswire)
12.06.24	Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum (Businesswire)
22.05.24	Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference (Businesswire)
15.05.24	Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software (Businesswire)
04.04.24	U.S. FDA Renews DILIsym® Software Licenses for 7th Year (Businesswire)
04.04.24	Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session (Benzinga)
20.03.24	Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date (Businesswire)
13.03.24	Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum (Businesswire)
05.03.24	Simulations Plus and the University of Bath Awarded New FDA Grant (Businesswire)
15.02.24	Simulations Plus Extends Collaboration with Major Toxicology Research Agency (Businesswire)
13.02.24	Simulations Plus Launches Corporate Development Initiative (Businesswire)
06.02.24	Simulations Plus to Participate in Upcoming Healthcare Conferences (Businesswire)
05.02.24	Simulations Plus Nurtures Growth and Provides Investors with Value. (Benzinga)
30.01.24	Simulations Plus Releases GastroPlus® Version 9.9 (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	4’040.00	1.71 %	K V
Geberit	547.80	1.59 %	K V
Part Grp Hldg	1’297.00	1.49 %	K V
ABB	51.94	1.29 %	K V
Swiss Life Hldg	691.80	1.26 %	K V
Zurich Insur Gr	548.00	-0.18 %	K V
Kuehne+Nagel Int	210.90	-0.33 %	K V
Swiss Re	128.20	-0.66 %	K V
Sonova Hldg	293.00	-0.85 %	K V
Novartis	87.94	-0.92 %	K V

Nachrichten zu Simulations Plus IncShs

Aktien Top/Flop

Meistgelesene Nachrichten